# Phase 2/3 Study of KPL-387 in Recurrent Pericarditis

> **NCT07010159** · PHASE2,PHASE3 · RECRUITING · sponsor: **Kiniksa Pharmaceuticals International, plc** · enrollment: 165 (estimated)

## Conditions studied

- Pericarditis
- Pericarditis Acute
- Recurrent Pericarditis

## Interventions

- **DRUG:** KPL-387
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07010159
- **Lead sponsor:** Kiniksa Pharmaceuticals International, plc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-25
- **Primary completion:** 2027-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07010159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07010159, "Phase 2/3 Study of KPL-387 in Recurrent Pericarditis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07010159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*